151 related articles for article (PubMed ID: 2502891)
1. Beta-2-microglobulin is a reliable tumor marker in chronic lymphocytic leukemia.
Di Giovanni S; Valentini G; Carducci P; Giallonardo P
Acta Haematol; 1989; 81(4):181-5. PubMed ID: 2502891
[TBL] [Abstract][Full Text] [Related]
2. Serum beta(2)-microglobulin and serum thymidine kinase are independent predictors of progression-free survival in chronic lymphocytic leukemia and immunocytoma.
Hallek M; Wanders L; Ostwald M; Busch R; Senekowitsch R; Stern S; Schick HD; Kuhn-Hallek I; Emmerich B
Leuk Lymphoma; 1996 Aug; 22(5-6):439-47. PubMed ID: 8882957
[TBL] [Abstract][Full Text] [Related]
3. Serum tumor markers in non-Hodgkin's lymphomas and chronic lymphocytic leukemia.
Pavlidis AN; Kalef-Ezra J; Bourantas LC; Lambrou A; Mavridis A
Int J Biol Markers; 1993; 8(1):14-20. PubMed ID: 8496627
[TBL] [Abstract][Full Text] [Related]
4. Interleukins, TNF-alpha and beta-2M in patients with B cell chronic lymphocytic leukemia.
Mavridis AK; Tsiara S; Makis A; Chaidos A; Christou L; Seferiadis K; Bourantas KL
J Exp Clin Cancer Res; 1998 Dec; 17(4):445-8. PubMed ID: 10089066
[TBL] [Abstract][Full Text] [Related]
5. Serum insulin-like growth factor is not elevated in patients with early B-cell chronic lymphocytic leukemia but is still a prognostic factor for disease progression.
Molica S; Vitelli G; Mirabelli R; Digiesu G; Giannarelli D; Cuneo A; Ribatti D; Vacca A
Eur J Haematol; 2006 Jan; 76(1):51-7. PubMed ID: 16343271
[TBL] [Abstract][Full Text] [Related]
6. Serum beta 2 microglobulin in malignant lymphoproliferative disorders.
Constantinides IP; Pathouli C; Karvountzis G; Papadopoulos P; Varvoutsi-Constantinides M; Eliakis P; Hadziyannis S; Komninos Z
Cancer; 1985 May; 55(10):2384-9. PubMed ID: 3886124
[TBL] [Abstract][Full Text] [Related]
7. Predictive value of beta2-microglobulin (beta2-m) levels in chronic lymphocytic leukemia since Binet A stages.
Gentile M; Cutrona G; Neri A; Molica S; Ferrarini M; Morabito F
Haematologica; 2009 Jun; 94(6):887-8. PubMed ID: 19483161
[No Abstract] [Full Text] [Related]
8. Evaluation of trisomy 12 by fluorescence in situ hybridization in peripheral blood, bone marrow and lymph nodes of patients with B-cell chronic lymphocytic leukemia.
Liso V; Capalbo S; Lapietra A; Pavone V; Guarini A; Specchia G
Haematologica; 1999 Mar; 84(3):212-7. PubMed ID: 10189384
[TBL] [Abstract][Full Text] [Related]
9. Production of beta 2-microglobulin by chronic lymphocytic leukaemia cells in vitro.
Simonsson B; Danersund A; Tötterman TH; Nilsson K; Wibell L
Scand J Haematol; 1986 May; 36(5):424-9. PubMed ID: 3526529
[TBL] [Abstract][Full Text] [Related]
10. Serum levels of tetranectin, intercellular adhesion molecule-1 and interleukin-10 in B-chronic lymphocytic leukemia.
Kamper EF; Papaphilis AD; Angelopoulou MK; Kopeikina LT; Siakantaris MP; Pangalis GA; Stavridis JC
Clin Biochem; 1999 Nov; 32(8):639-45. PubMed ID: 10638947
[TBL] [Abstract][Full Text] [Related]
11. Clinico-biological implications of increased serum levels of interleukin-8 in B-cell chronic lymphocytic leukemia.
Molica S; Vitelli G; Levato D; Levato L; Dattilo A; Gandolfo GM
Haematologica; 1999 Mar; 84(3):208-11. PubMed ID: 10189383
[TBL] [Abstract][Full Text] [Related]
12. Beta 2-microglobulin in chronic lymphocytic leukaemia.
Simonsson B; Wibell L; Nilsson K
Scand J Haematol; 1980 Feb; 24(2):174-80. PubMed ID: 6154964
[TBL] [Abstract][Full Text] [Related]
13. GM-CSF raises serum levels of beta 2-microglobulin and thymidine kinase in patients with chronic lymphocytic leukaemia.
Itälä M; Pelliniemi TT; Remes K
Br J Haematol; 1996 Jul; 94(1):129-32. PubMed ID: 8757522
[TBL] [Abstract][Full Text] [Related]
14. Clinico-prognostic implications of simultaneous increased serum levels of soluble CD23 and beta2-microglobulin in B-cell chronic lymphocytic leukemia.
Molica S; Levato D; Cascavilla N; Levato L; Musto P
Eur J Haematol; 1999 Feb; 62(2):117-22. PubMed ID: 10052715
[TBL] [Abstract][Full Text] [Related]
15. [Clinical and laboratory prognostic parameters for leukemic types of chronic lymphoproliferative diseases].
Kardum-Skelin I; Planinc-Peraica A; Ostojić Kolonić S; Radić-Kristo D; Milas M; Vrhovac R; Sustercić D; Minigo H; Jaksić B
Acta Med Croatica; 2008 Oct; 62(4):351-64. PubMed ID: 19205412
[TBL] [Abstract][Full Text] [Related]
16. Prognostic relevance of serum levels and cellular expression of adiponectin in B-cell chronic lymphocytic leukemia.
Molica S; Vitelli G; Cutrona G; Todoerti K; Mirabelli R; Digiesi G; Giannarelli D; Sperduti I; Molica M; Gentile M; Morabito F; Neri A; Ferrarini M
Int J Hematol; 2008 Nov; 88(4):374-380. PubMed ID: 18818986
[TBL] [Abstract][Full Text] [Related]
17. Prognostic value of plasma interleukin-6 levels in patients with chronic lymphocytic leukemia.
Lai R; O'Brien S; Maushouri T; Rogers A; Kantarjian H; Keating M; Albitar M
Cancer; 2002 Sep; 95(5):1071-5. PubMed ID: 12209693
[TBL] [Abstract][Full Text] [Related]
18. Prognostic relevance of a scoring system based on clinical and biological parameters in early chronic lymphocytic leukemia.
Leotard S; Chastang C; Travade P; Jaudon MC; Tournilhac O; Baudet S; Merle-Beral H
Hematol J; 2000; 1(5):301-6. PubMed ID: 11920207
[TBL] [Abstract][Full Text] [Related]
19. Telomerase activity is not a prognostic factor in chronic lymphocytic leukemia.
Verstovsek S; Giles FJ; O'Brien S; Faderl S; Kantarjian HM; Keating MJ; Albitar M
Leuk Res; 2004 Jul; 28(7):707-11. PubMed ID: 15158092
[TBL] [Abstract][Full Text] [Related]
20. Early chronic lymphocytic leukemia: prognostic value of quantitative bone marrow MR imaging findings and correlation with hematologic variables.
Lecouvet FE; Vande Berg BC; Michaux L; Schmitz PJ; Malghem J; Jamart J; Maldague BE; Ferrant A; Michaux JL
Radiology; 1997 Sep; 204(3):813-8. PubMed ID: 9280265
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
